Donepezil in Alzheimer’s Disease: What to Expect after 3 Years of Treatment in a Routine Clinical Setting

Publisher： Karger

E-ISSN： 1421-9824|23|3|150-160

ISSN： 1420-8008

Source： Dementia and Geriatric Cognitive Disorders, Vol.23, Iss.3, 2006-12, pp. : 150-160

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

An Observational Clinical Study of the Efficacy and Tolerability of Donepezil in the Treatment of Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 15, Iss. 4, 2003-03 ,pp. : 189-198

Karger

Access to resources Recommend Favorite

Perspectives in the Management of Alzheimer’s Disease: Clinical Profile of Donepezil

By  

Dementia and Geriatric Cognitive Disorders, Vol. 9, Iss. 3, 1998-10 ,pp. : 29-42

Karger

Access to resources Recommend Favorite

Donepezil for Alzheimer’s Disease in Clinical Practice – The DONALD Study

By  

Dementia and Geriatric Cognitive Disorders, Vol. 18, Iss. 1, 2004-06 ,pp. : 37-43

Karger

Access to resources Recommend Favorite

Economic Evaluation of Donepezil Treatment for Alzheimer’s Disease in Japan

By  

Dementia and Geriatric Cognitive Disorders, Vol. 13, Iss. 1, 2001-12 ,pp. : 33-39

Karger

Access to resources Recommend Favorite

Chronic Donepezil Treatment Is Associated with Slowed Cognitive Decline in Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 12, Iss. 4, 2001-05 ,pp. : 295-300

Karger

Access to resources Recommend Favorite